Constipation during GLP-1 treatment: what research records

How trial reports differ from persistent constipation, and what information makes a clinical discussion more useful.

In this guide

A trial percentage does not describe every episode

Constipation was reported in Zepbound weight-reduction trials, but an event table does not tell a reader exactly how long each episode lasted or how disruptive it was. A participant with one episode and someone with repeated symptoms can both appear in the numerator. Therefore, a percentage alone is not a forecast of your daily experience. Look for severity, duration and discontinuation information before assuming the table describes a typical course.[1]

Frequency is only part of the definition

NIDDK describes constipation using more than the number of bowel movements: hard stools, painful or difficult passage and a sense of incomplete emptying also matter. A person can have a problem even if their frequency does not match an internet rule of thumb. For a clinical conversation, describe what changed from your usual pattern and how it affects you. This gives the clinician more information than simply selecting “constipation” in a form.[2]

Keep a practical symptom record

For a short period, note the timing of bowel movements, stool difficulty, abdominal symptoms and relevant medication changes. Include other prescriptions and supplements rather than assuming the GLP-1 is the only possible contributor. The purpose is not to diagnose yourself from a log. It is to give the care team a usable sequence of events and reduce uncertainty when deciding what assessment or treatment is appropriate. For a related question, see reflux symptoms and assessment.

Persistent symptoms deserve a response

NIDDK recommends talking to a clinician when constipation persists despite self-care or is long lasting. Bleeding, blood in the stool or continual abdominal pain are reasons to seek medical evaluation. Do not interpret the fact that constipation appears in a trial table as a reason to tolerate worsening symptoms indefinitely. A recognized adverse event can still require an individualized assessment, particularly when other concerning features are present.[2]

Postmarketing reports do not give a personal probability

Safety information after approval can include more serious gastrointestinal events, but spontaneous reports do not provide a reliable frequency for everyone using a drug. That distinction prevents two errors: dismissing a serious report because it is uncommon, or treating every ordinary episode as proof of a severe complication. A clinician evaluates the actual symptoms. The research reader should keep event type and evidence source visible. Related reading: interpreting safety evidence.

Avoid stacking remedies without a review

A list of products recommended by strangers is not a treatment plan. Before combining nonprescription remedies or changing the prescribed medicine, ask the clinician or pharmacist how the options fit your history and other medicines. Explain what you have already tried so advice does not accidentally duplicate it. This article does not provide a laxative schedule or a medication adjustment because those choices depend on circumstances a general trial summary cannot establish.

Ask how the clinic handles ongoing symptoms

At enrollment, establish how a symptom report reaches a clinician and whether follow-up is available between renewals. If an automated form keeps approving refills without addressing a persistent complaint, request clinical review. A useful service explains where its role ends and when in-person assessment is needed. Compare this process alongside price and convenience; knowing the contact route before a problem occurs is more valuable than an unspecified promise of support. Related reading: provider follow-up questions.

Continue your research

Sources & scope

Sources checked October 13, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.

  1. Zepbound prescribing information
  2. NIDDK: constipation

Prices and terms can change. Confirm your specific offer directly with the provider.

One more option